Annual Shareholders Equity
$37.09 M
-$28.60 M-43.54%
31 December 2023
Summary:
Cue Biopharma annual stockholders equity is currently $37.09 million, with the most recent change of -$28.60 million (-43.54%) on 31 December 2023. During the last 3 years, it has fallen by -$28.41 million (-43.37%). CUE annual shareholders equity is now -53.00% below its all-time high of $78.91 million, reached on 31 December 2020.CUE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$25.37 M
+$3.74 M+17.32%
30 September 2024
Summary:
Cue Biopharma quarterly stockholders equity is currently $25.37 million, with the most recent change of +$3.74 million (+17.32%) on 30 September 2024. Over the past year, it has dropped by -$11.72 million (-31.60%). CUE quarterly shareholders equity is now -71.03% below its all-time high of $87.55 million, reached on 30 September 2020.CUE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CUE Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -31.6% |
| 3 y3 years | -43.4% | -61.3% |
| 5 y5 years | -32.1% | -53.5% |
CUE Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.5% | at low | -61.4% | +17.3% |
| 5 y | 5 years | -53.0% | at low | -71.0% | +17.3% |
| alltime | all time | -53.0% | +434.5% | -71.0% | +479.0% |
Cue Biopharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $25.37 M(+17.3%) |
| June 2024 | - | $21.62 M(-28.0%) |
| Mar 2024 | - | $30.04 M(-19.0%) |
| Dec 2023 | $37.09 M(-43.5%) | $37.09 M(-13.1%) |
| Sept 2023 | - | $42.67 M(-7.3%) |
| June 2023 | - | $46.00 M(-16.4%) |
| Mar 2023 | - | $55.02 M(-16.2%) |
| Dec 2022 | $65.68 M(+0.3%) | $65.68 M(+29.4%) |
| Sept 2022 | - | $50.76 M(-15.0%) |
| June 2022 | - | $59.76 M(-7.6%) |
| Mar 2022 | - | $64.67 M(-1.3%) |
| Dec 2021 | $65.49 M(-17.0%) | $65.49 M(+3.1%) |
| Sept 2021 | - | $63.52 M(-12.9%) |
| June 2021 | - | $72.91 M(+4.7%) |
| Mar 2021 | - | $69.67 M(-11.7%) |
| Dec 2020 | $78.91 M | $78.91 M(-9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $87.55 M(+9.2%) |
| June 2020 | - | $80.15 M(+77.2%) |
| Mar 2020 | - | $45.24 M(-17.1%) |
| Dec 2019 | $54.58 M(+60.7%) | $54.58 M(+102.0%) |
| Sept 2019 | - | $27.02 M(+33.2%) |
| June 2019 | - | $20.28 M(-18.0%) |
| Mar 2019 | - | $24.74 M(-27.2%) |
| Dec 2018 | $33.97 M(-44.9%) | $33.97 M(-13.8%) |
| Sept 2018 | - | $39.40 M(-20.0%) |
| June 2018 | - | $49.23 M(-10.9%) |
| Mar 2018 | - | $55.24 M(-10.3%) |
| Dec 2017 | $61.61 M(+306.0%) | $61.61 M(+1306.3%) |
| Sept 2017 | - | $4.38 M(-49.4%) |
| June 2017 | - | $8.66 M(-42.9%) |
| Dec 2016 | $15.17 M(+118.7%) | $15.17 M |
| Dec 2015 | $6.94 M | - |
FAQ
- What is Cue Biopharma annual stockholders equity?
- What is the all time high annual shareholders equity for Cue Biopharma?
- What is Cue Biopharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cue Biopharma?
- What is Cue Biopharma quarterly shareholders equity year-on-year change?
What is Cue Biopharma annual stockholders equity?
The current annual shareholders equity of CUE is $37.09 M
What is the all time high annual shareholders equity for Cue Biopharma?
Cue Biopharma all-time high annual stockholders equity is $78.91 M
What is Cue Biopharma quarterly stockholders equity?
The current quarterly shareholders equity of CUE is $25.37 M
What is the all time high quarterly shareholders equity for Cue Biopharma?
Cue Biopharma all-time high quarterly stockholders equity is $87.55 M
What is Cue Biopharma quarterly shareholders equity year-on-year change?
Over the past year, CUE quarterly stockholders equity has changed by -$11.72 M (-31.60%)